Our succes in integrating information into models that generate unique insights, allowing executives to make better drug development decisions, is reflected in our gold-standard research publications.
Population Pharmacokinetics of Letermovir Following Oral and Intravenous Administration in Healthy Participants and Allogeneic Hematopoietic Cell Transplantation Recipients | Infectious diseases
Prohn M et al. | qP contributors: Prohn M | 2021| Journal| CPT: Pharmacometrics & Systems Pharmacology Link
Exposure–Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIII | Haematology
Jonsson F et al. | qP contributors: Jonsson F | 2021| Journal| Clinical Pharmacokinetics Link
Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis | Immunology
Chan P et al. | qP contributors: Prohn M, Huisman J, Matzuka B | 2020| Journal| Pharmaceutical Research Link